This topic contains a solution. Click here to go to the answer

Author Question: A defense that shields police officersfrom criminal liability when performing certain official ... (Read 74 times)

bobypop

  • Hero Member
  • *****
  • Posts: 539
A defense that shields police officersfrom criminal liability when performing certain official functions, such as using deadly force, is referred to as:
 
  a. public duty defense.
  b. immunity defense.
  c. injunctive relief defense.
  d. exception defense.

Question 2

To be held liable under Section 242, a law enforcement officer must:
 
  a. negate a person's rights without forethought.
  b. unintentionally deny an individual his or her rights.
  c. act with specific intent to deprive a person of important constitutional (or other federal) rights.
  d. inadvertently impose restrictions on a person's constitutional rights.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

yifu223

  • Sr. Member
  • ****
  • Posts: 302
Answer to Question 1

a

Answer to Question 2

c





 

Did you know?

Vampire bats have a natural anticoagulant in their saliva that permits continuous bleeding after they painlessly open a wound with their incisors. This capillary blood does not cause any significant blood loss to their victims.

Did you know?

It is difficult to obtain enough calcium without consuming milk or other dairy foods.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Hip fractures are the most serious consequences of osteoporosis. The incidence of hip fractures increases with each decade among patients in their 60s to patients in their 90s for both women and men of all populations. Men and women older than 80 years of age show the highest incidence of hip fractures.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library